However, the identifier "0302" frequently appears in the context of on ClinicalTrials.gov , particularly focusing on:
If it is related to a , I can look up the specific protocol ID if you have it. PN-018-0302.7z
Based on the search results, there is no direct reference to a published paper specifically named or indexed under the filename "." However, the identifier "0302" frequently appears in the
A Phase II study of LM-302 combined with toripalimab for CLDN18.2 positive gastro-intestinal cancer, which was discussed at ASCO 2025. PN-018-0302.7z
Effect of 3 Years of Exercise on Development of Atrial Fibrillation